Bank of Montreal
CNST

Bank of Montreal’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Bank of Montreal’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-16,200
Closed -$370K – 5475
2021
Q1 		$370K Buy
+16,200
New +$491K ﹤0.01% 2823

Other funds holding CNST

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
OPU
Omni Partners US Irvine, California $1.95B AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return
PIM
Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of Montreal's CNST Position: Q2 2021 in Review

Bank of Montreal sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q2 2021, closing a stake of 941 shares — an estimated $21K sold.

Bank of Montreal first reported a position in CNST in Q3 2018 and held it in 11 quarters. The position peaked at $130K in Q4 2020. 153 funds tracked by Wall St. Rank hold CNST as of Q2 2021.

  • Bank of Montreal reported no remaining Constellation Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 941 Constellation Pharmaceuticals, Inc. shares in Q2 2021, an estimated $21K.
  • Bank of Montreal first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2018 and held it in 11 quarters.
  • Bank of Montreal's Constellation Pharmaceuticals, Inc. position peaked at $130K in Q4 2020.
  • 153 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.